CA - Psychedelic drug developer Cybin completes acquisition of Small Pharma
2023-10-23 15:05:20 ET
More on Cybin
- Cybin Inc. 2023 FQ1 - Results - Earnings Call Presentation
- Psychedelic drugs market to break $7B in 2029 led by these 3 meds
- Cybin in pact to support training in Phase 3 psychedelic trial
- Seeking Alpha’s Quant Rating on Cybin
- Historical earnings data for Cybin
For further details see:
Psychedelic drug developer Cybin completes acquisition of Small Pharma